Авторы

  • A.M. Raxmatov

DOI:

https://doi.org/10.71337/inlibrary.uz.zdift.51988

Аннотация

Podagra — bu organizmda siyanid kislotalarining (urik kislota) to'planishi natijasida yuzaga keladigan metabolik kasallik bo'lib, asosan erkaklar orasida uchraydi. Bu kasallikning asosiy sababi buyraklarning urik kislota miqdorini to'g'ri chiqarishdagi muammolaridir. Podagrik nefropatiya esa podagraga chalingan bemorlarda buyrakning zararlanishi va funksional o'zgarishlar bilan tavsiflanadi. Bu ikki kasallik bir-biri bilan chambarchas bog'liq bo'lib, vaqtida tashxis qo‘yish va davolash bemorning holatini sezilarli darajada yaxshilashga yordam beradi. Podagrik nefropatiya, shuningdek, buyrak yetishmovchiligi va boshqa asoratlarning rivojlanishiga olib kelishi mumkin.


background image

`

120

PODAGRA VA UNING PODAGRIK NEFROPATIYA BILAN ALOQASI: 46TA

BEMOR MISOLIDA TAHLIL

Raxmatov A.M.

https://doi.org/10.5281/zenodo.14258376

Kirish:

Podagra — bu organizmda siyanid kislotalarining (urik kislota) to'planishi

natijasida yuzaga keladigan metabolik kasallik bo'lib, asosan erkaklar orasida uchraydi. Bu
kasallikning asosiy sababi buyraklarning urik kislota miqdorini to'g'ri chiqarishdagi
muammolaridir. Podagrik nefropatiya esa podagraga chalingan bemorlarda buyrakning
zararlanishi va funksional o'zgarishlar bilan tavsiflanadi. Bu ikki kasallik bir-biri bilan
chambarchas bog'liq bo'lib, vaqtida tashxis qo‘yish va davolash bemorning holatini sezilarli
darajada yaxshilashga yordam beradi. Podagrik nefropatiya, shuningdek, buyrak
yetishmovchiligi va boshqa asoratlarning rivojlanishiga olib kelishi mumkin.

Maqsad:

Ushbu tezisning maqsadi podagra va podagrik nefropatiya o'rtasidagi aloqani

tahlil qilish, ushbu kasalliklarning xavf omillarini aniqlash va davolashning samaradorligini
baholashdir.

Ma‘lumotlar:

1.

Bemorlarning umumiy soni: Podagraga chalingan bemorlar soni 46 nafarni tashkil etadi.

Ulardan 3 nafarini ayollar, 44 nafarini erkaklar tashkil qiladi.
2.

Yoshlar tarkibi: Bemorlarga 40-70 yosh oralig'ida podagra tashxisi qo'yilgan, bu esa

kasallikning o'rta va keksaygan yoshdagi insonlarda ko'proq uchrashini ko'rsatadi.
3.

Podagrik nefropatiya: Podagrik nefropatiya 20 ta erkak bemorda aniqlangan, bu

bemorlarning 15 tasi 50 yoshdan yuqori. Bu ma'lumot podagrik nefropatiya kasalligi ko'proq
o‘rta yosh va undan katta erkaklar orasida rivojlanishini ko‘rsatadi.
4.

Yosh guruhlari: Umumiy bemorlarning 23 tasi 50 yoshdan katta, bu esa podagra

kasalligining o'rta yosh va undan katta insonlarda ko'proq uchrashini ko'rsatadi.

Tahlil

: odagra ko'pincha erkaklarda uchraydi, bu esa erkaklarning 44 ta bemordan 20

tasida podagrik nefropatiya aniqlanganini tushuntiradi. Shuningdek, 50 yoshdan oshgan
bemorlarda podagrik nefropatiya rivojlanish ehtimoli yuqori ekanligi ma'lum bo'ldi. Ushbu
natijalar podagra kasalligining yuqori yoshdagi erkaklarda ko'proq uchrayotganini va ular
orasida podagrik nefropatiyaning tez rivojlanishini ko'rsatadi.

Podagra va podagrik nefropatiyaning rivojlanishiga turli omillar, jumladan, irsiyat, dieta,

qon bosimi, diabet va boshqa metabolik kasalliklar ta'sir ko'rsatishi mumkin. Bu
kasalliklarning tez rivojlanishi va kech tahlil qilinishi buyraklar uchun xavf tug'diradi. Bu holat
buyrak yetishmovchiligi kabi og'ir asoratlarga olib kelishi mumkin. Shu sababli, podagraga
chalingan bemorlarda buyrak funksiyasini muntazam tekshirish va erta davolash muhimdir.

Xulosa:

Podagrik nefropatiya podagra kasalligiga chalingan bemorlarda keng tarqalgan

bo'lib, ayniqsa 50 yoshdan katta erkaklar orasida. Podagra va uning asoratlari, xususan
podagrik nefropatiya, bemorlar salomatligini jiddiy ravishda ta'sir qilishi mumkin, shuning
uchun ushbu kasallikni erta aniqlash va davolash uchun samarali profilaktik chora-tadbirlar
zarur.


background image

`

121

References:

1.

Toto, R. L., & Johnson, R. J. (2017). Gout and hyperuricemia: An update on

pathophysiology, diagnosis, and management. Nephrology Dialysis Transplantation, 32(9),
1450-1460.
2.

Choi, H. K., & Curhan, G. (2007). Independent impact of gout on mortality and risk for

coronary heart disease. Circulation, 116(7), 894-900.
3.

Li, C., Hsieh, M. C., & Chang, S. J. (2015). Gout and kidney disease: Review and update.

Journal of Clinical Rheumatology, 21(6), 349-354.
4.

Abhishek, A., & Doherty, M. (2017). The epidemiology of gout: The UK perspective.

Rheumatology, 56(4), 476-484.
5.

Zhang, W., & Doherty, M. (2012). Gout management and its impact on the burden of

disease in developed countries. Arthritis & Rheumatism, 64(4), 1101-1111.
6.

Jabbarov, O. O., Maksudova, M. H., Mirzayeva, G. P., & Rakhmatov, A. M. (2023). The

Relationship of Blood Group with Human Diseases.

Web of Semantic: Universal Journal on

Innovative Education

,

2

(3), 331-334.

7.

Rakhmatov, A. M., & Jabbarov, A. A.

KodirovaSh. A., Jumanazarov SB (2022). CLINICAL

MANIFESTATIONS OF GOUTHY NEPHROPATHY. THEORETICAL ASPECTS IN THE FORMATION
OF PEDAGOGICAL SCIENCES, 1 (6), 140–141

.

8.

Fayzullaevna, M. G., Otakhanovich, J. O., Tokhirovna, B. N., Mamatovich, R. A., &

Bakhadirovich, J. S. (2022). Gout Therapy With Reduced Kidney Function.

Central Asian

Journal of Medical and Natural Science

,

3

(6), 198-203.

Библиографические ссылки

Toto, R. L., & Johnson, R. J. (2017). Gout and hyperuricemia: An update on pathophysiology, diagnosis, and management. Nephrology Dialysis Transplantation, 32(9), 1450-1460.

Choi, H. K., & Curhan, G. (2007). Independent impact of gout on mortality and risk for coronary heart disease. Circulation, 116(7), 894-900.

Li, C., Hsieh, M. C., & Chang, S. J. (2015). Gout and kidney disease: Review and update. Journal of Clinical Rheumatology, 21(6), 349-354.

Abhishek, A., & Doherty, M. (2017). The epidemiology of gout: The UK perspective. Rheumatology, 56(4), 476-484.

Zhang, W., & Doherty, M. (2012). Gout management and its impact on the burden of disease in developed countries. Arthritis & Rheumatism, 64(4), 1101-1111.

Jabbarov, O. O., Maksudova, M. H., Mirzayeva, G. P., & Rakhmatov, A. M. (2023). The Relationship of Blood Group with Human Diseases. Web of Semantic: Universal Journal on Innovative Education, 2(3), 331-334.

Rakhmatov, A. M., & Jabbarov, A. A. KodirovaSh. A., Jumanazarov SB (2022). CLINICAL MANIFESTATIONS OF GOUTHY NEPHROPATHY. THEORETICAL ASPECTS IN THE FORMATION OF PEDAGOGICAL SCIENCES, 1 (6), 140–141.

Fayzullaevna, M. G., Otakhanovich, J. O., Tokhirovna, B. N., Mamatovich, R. A., & Bakhadirovich, J. S. (2022). Gout Therapy With Reduced Kidney Function. Central Asian Journal of Medical and Natural Science, 3(6), 198-203.